{"Abstract": [0], "Immunotherapy": [1], "has": [2], "revolutionized": [3], "cancer": [4, 40, 71, 159, 190, 205, 226], "treatment": [5], "and": [6, 22, 36, 64, 102, 128, 138, 167, 176, 186, 217], "rejuvenated": [7], "the": [8, 49, 67, 83, 92, 99, 106, 109, 134, 143, 155, 168, 179, 202, 208, 220], "field": [9], "of": [10, 15, 39, 70, 75, 85, 94, 105, 112, 133, 146, 172, 182, 201, 210, 222], "tumor": [11, 50, 62, 215], "immunology.": [12], "Several": [13], "types": [14], "immunotherapy,": [16, 160, 206], "including": [17], "adoptive": [18], "cell": [19, 212], "transfer": [20], "(ACT)": [21], "immune": [23, 77, 114, 148, 174, 184, 211], "checkpoint": [24], "inhibitors": [25], "(ICIs),": [26], "have": [27, 53], "obtained": [28], "durable": [29], "clinical": [30, 68], "responses,": [31], "but": [32], "their": [33, 187], "efficacies": [34], "vary,": [35], "only": [37], "subsets": [38], "patients": [41], "can": [42], "benefit": [43], "from": [44], "them.": [45], "Immune": [46], "infiltrates": [47], "in": [48, 61, 119, 158, 204, 214], "microenvironment": [51], "(TME)": [52], "been": [54], "shown": [55], "to": [56], "play": [57], "a": [58, 195], "key": [59], "role": [60], "development": [63, 93, 221], "will": [65, 139], "affect": [66], "outcomes": [69], "patients.": [72], "Comprehensive": [73], "profiling": [74], "tumor-infiltrating": [76, 147], "cells": [78, 185], "would": [79], "shed": [80], "light": [81], "on": [82, 164], "mechanisms": [84], "cancer\u2013immune": [86], "evasion,": [87], "thus": [88, 218], "providing": [89], "opportunities": [90], "for": [91, 225], "novel": [95, 223], "therapeutic": [96], "strategies.": [97], "However,": [98], "highly": [100], "heterogeneous": [101], "dynamic": [103], "nature": [104], "TME": [107, 135], "impedes": [108], "precise": [110], "dissection": [111], "intratumoral": [113, 183], "cells.": [115, 149], "With": [116], "recent": [117, 156, 169], "advances": [118], "single-cell": [120, 124, 170], "technologies": [121], "such": [122, 194], "as": [123], "RNA": [125], "sequencing": [126], "(scRNA-seq)": [127], "mass": [129], "cytometry,": [130], "systematic": [131], "interrogation": [132], "is": [136], "feasible": [137], "provide": [140], "insights": [141], "into": [142], "functional": [144], "diversities": [145, 181], "In": [150], "this": [151], "review,": [152], "we": [153, 177], "outline": [154], "progress": [157, 203], "particularly": [161], "by": [162], "focusing": [163], "landmark": [165], "studies": [166], "characterization": [171], "tumor-associated": [173], "cells,": [175], "summarize": [178], "phenotypic": [180], "connections": [188], "with": [189], "immunotherapy.": [191], "We": [192], "believe": [193], "review": [196], "could": [197], "strengthen": [198], "our": [199], "understanding": [200], "facilitate": [207], "elucidation": [209], "modulation": [213], "progression,": [216], "guide": [219], "immunotherapies": [224], "treatment.": [227]}